Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger D Porsolt

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Fundamental & Clinical Pharmacology|August 8, 2002
New perspectives in CNS safety pharmacologyRoger D Porsolt, Martine Lemaire, Niklaus Dürmüller, et al.
European Journal of Pharmacology|February 29, 2008
Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the ratDieter Scheller, Nick Dürmüller, Paul Moser, et al.
Current Protocols in Pharmacology|February 2, 2012
Place preference test in rodentsSylvain Roux, Christelle Froger, Roger D Porsolt, et al.
Current Protocols in Neuroscience|April 23, 2008
Place preference test in rodentsSylvain Roux, Christelle Froger, Roger D Porsolt, et al.
Journal of Pharmacological and Toxicological Methods|June 26, 2007
The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant riskNiklaus Dürmüller, Philippe Guillaume, Pierre Lacroix, et al.
Journal of Pharmacological and Toxicological Methods|March 17, 2011
Continuous evaluation of drug withdrawal in the rat using telemetry: effects of morphine and chlordiazepoxideChristelle Froger-Colléaux, Sonia Rompion, Philippe Guillaume, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonistGerard B Fox, Timothy A Esbenshade, Jia Bao Pan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Fundamental & Clinical Pharmacology|August 8, 2002
New perspectives in CNS safety pharmacologyRoger D Porsolt, Martine Lemaire, Niklaus Dürmüller, et al.
European Journal of Pharmacology|February 29, 2008
Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the ratDieter Scheller, Nick Dürmüller, Paul Moser, et al.
Current Protocols in Pharmacology|February 2, 2012
Place preference test in rodentsSylvain Roux, Christelle Froger, Roger D Porsolt, et al.
Current Protocols in Neuroscience|April 23, 2008
Place preference test in rodentsSylvain Roux, Christelle Froger, Roger D Porsolt, et al.
Journal of Pharmacological and Toxicological Methods|June 26, 2007
The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant riskNiklaus Dürmüller, Philippe Guillaume, Pierre Lacroix, et al.
Journal of Pharmacological and Toxicological Methods|March 17, 2011
Continuous evaluation of drug withdrawal in the rat using telemetry: effects of morphine and chlordiazepoxideChristelle Froger-Colléaux, Sonia Rompion, Philippe Guillaume, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonistGerard B Fox, Timothy A Esbenshade, Jia Bao Pan, et al.
Pageof 2